Most cases of NMOSD present with symptoms of either optic neuritis or transverse myelitis, if not symptoms of both, but some cases of brain abnormalities without optic neuritis or longitudinally ...
SAN DIEGO — Treatment with daratumumab, a monoclonal antibody approved to treat multiple myeloma, was associated with a significant decrease in relapse risk in patients with aquaporin-4 immunoglobulin ...
A curative treatment for NMOSD does not currently exist. The main treatment goals are remission, long-term stabilization of disease course by means of relapse prevention and residual symptom relief.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results